Marcela M Blascke de Mello

Matrix metalloproteinase (MMP)-2 activation by oxidative stress decreases aortic calponin-1 levels during hypertrophic remodeling in early hypertension.

R. Schulz, M. Castro, J. M. Parente, 2019, Vascular pharmacology.

Verapamil decreases calpain-1 and matrix metalloproteinase-2 activities and improves hypertension-induced hypertrophic cardiac remodeling in rats.

J. Tanus-Santos, R. Fazan, J. Parente, 2019, Life sciences.

Mineralocorticoid receptors contribute to ethanol-induced vascular hypercontractility through reactive oxygen species generation and up-regulation of cyclooxygenase 2.

E. Cárnio, M. Castro, Wanessa M C Awata, 2023, European journal of pharmacology.

Type I collagen proteolysis by matrix metalloproteinase-2 contributes to focal adhesion kinase activation and vascular smooth muscle cell proliferation in the aorta in early hypertension.

E. Arantes, R. Tostes, Daniel Rodrigues, 2023, Vascular pharmacology.

The hydrogen sulfide donor 4-carboxyphenyl-isothiocyanate decreases blood pressure and promotes cardioprotective effect through reduction of oxidative stress and nuclear factor kappa B/matrix metalloproteinase (MMP)-2 axis in hypertension.

J. Tanus-Santos, L. Elias, J. M. Parente, 2024, Life sciences.

Sarcoplasmic reticulum calcium ATPase (SERCA) proteolysis by matrix metalloproteinase-2 contributes to vascular dysfunction in early hypertension.

J. M. Parente, Marcela M Blascke de Mello, C. Tirapelli, 2024, European journal of pharmacology.